These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15073842)

  • 1. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy of colon cancer: current status and future developments.
    Morse MA
    Clin Colon Rectal Surg; 2005 Aug; 18(3):224-31. PubMed ID: 20011305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining chemotherapy and targeted therapies in metastatic colorectal cancer.
    Rodriguez J; Zarate R; Bandres E; Viudez A; Chopitea A; García-Foncillas J; Gil-Bazo I
    World J Gastroenterol; 2007 Nov; 13(44):5867-76. PubMed ID: 17990352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Developments in Cytotoxic Therapy for Advanced Gastric or Gastroesophageal Carcinoma: The Phase III Trials.
    Ajani JA
    Gastrointest Cancer Res; 2007 Mar; 1(2 Suppl):S16-21. PubMed ID: 19343156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.
    Puthillath A; Patel A; Fakih MG
    Onco Targets Ther; 2009 Feb; 2():1-15. PubMed ID: 20616890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in treating metastatic colorectal cancer: Recent international reports from ASCO 2007 and 2008.
    Ducreux M
    Clin Exp Gastroenterol; 2009; 2():13-9. PubMed ID: 21694822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic treatment of advanced colorectal cancer: tailoring therapy to the tumor.
    Carethers JM
    Therap Adv Gastroenterol; 2008 Jul; 1(1):33-42. PubMed ID: 21180512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and prognostic markers in colorectal cancer.
    Wilson PM; Ladner RD; Lenz HJ
    Gastrointest Cancer Res; 2007 Nov; 1(6):237-46. PubMed ID: 19262902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Therapeutic Efficacy of the Nanoscale Fluoropyrimidine Polymer CF10 in a Rat Colorectal Cancer Liver Metastasis Model.
    Okechukwu CC; Ma X; Sah N; Mani C; Palle K; Gmeiner WH
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged survival in metastatic colorectal cancer following chemotherapy.
    Paul D; Gold M; Nouraddin N
    Clin Case Rep; 2014 Oct; 2(5):219-23. PubMed ID: 25614815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
    Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A
    J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathway.
    Wang H; Liu Y; Ding J; Huang Y; Liu J; Liu N; Ao Y; Hong Y; Wang L; Zhang L; Wang J; Zhang Y
    Cancer Gene Ther; 2020 Jun; 27(6):448-460. PubMed ID: 31257364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts.
    Zhang M; Chen C; Su F; Huang Z; Li X; Li X
    Technol Cancer Res Treat; 2017 Oct; 16(5):609-619. PubMed ID: 27573201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
    Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
    Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecularly targeted drugs for the treatment of cancer: oral complications and pathophysiology.
    Dietrich E; Antoniades K
    Hippokratia; 2012 Jul; 16(3):196-9. PubMed ID: 23935282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer.
    Satram-Hoang S; Lee L; Yu S; Guduru SR; Gunuganti AR; Reyes C; McKenna E
    J Gastrointest Cancer; 2013 Mar; 44(1):79-88. PubMed ID: 23132351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
    Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
    World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete Response of Isolated Para-aortic Lymph Node Recurrence from Rectosigmoid Cancer Treated by Chemoradiation Therapy with Capecitabine/Oxaliplatin plus Bevacizumab: A Case Report.
    Miyazawa T; Ebe K; Koide N; Fujita N
    Case Rep Oncol; 2012 May; 5(2):216-21. PubMed ID: 22679426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates.
    Marcus L; Murphy R; Fox E; McCully C; Cruz R; Warren KE; Meyer T; McNiff E; Balis FM; Widemann BC
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):247-52. PubMed ID: 21706317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capecitabine for locally advanced and metastatic colorectal cancer: A review.
    Koukourakis GV; Zacharias G; Tsalafoutas J; Theodoridis D; Kouloulias V
    World J Gastrointest Oncol; 2010 Aug; 2(8):311-21. PubMed ID: 21160892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.